Trial Profile
A phase I trial of Cabazitaxel for breast cancer
Status:
Planning
Phase of Trial:
Phase I
Latest Information Update: 30 Nov 2017
Price :
$35
*
At a glance
- Drugs Cabazitaxel (Primary)
- Indications Breast cancer
- Focus Adverse reactions
- 30 Nov 2017 New trial record